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Background: The referral letter plays a key role both in the communication between primary and secondary care,
and in the quality of the health care process. Many studies have attempted to evaluate and improve the quality of
these referral letters, but few have assessed the impact of their quality on the health care delivered to each patient.
Methods: A cluster randomized trial, with the general practitioner office as the unit of randomization, has been
designed to evaluate the effect of a referral intervention on the quality of health care delivered. Referral templates
have been developed covering four diagnostic groups: dyspepsia, suspected colonic malignancy, chest pain, and
chronic obstructive pulmonary disease. Of the 14 general practitioner offices primarily served by University Hospital
of North Norway Harstad, seven were randomized to the intervention group. The primary outcome is a collated
quality indicator score developed for each diagnostic group. Secondary outcomes include: quality of the referral,
health process outcome such as waiting times, and adequacy of prioritization. In addition, information on patient
satisfaction will be collected using self-report questionnaires. Outcome data will be collected on the individual level
and analyzed by random effects linear regression.
Discussion: Poor communication between primary and secondary care can lead to inappropriate investigations
and erroneous prioritization. This study’s primary hypothesis is that the use of a referral template in this
communication will lead to a measurable increase in the quality of health care delivered.
Trial registration: This trial has been registered at ClinicalTrials.gov. The trial registration number is NCT01470963
Keywords: Cluster randomized trial, General practice, Quality of care, ReferralBackground
Quality of healthcare is defined by the American Institute
of Medicine as ‘the degree to which health services for indi-
viduals and populations increase the likelihood of desired
health outcomes and are consistent with current profes-
sional knowledge’ [1]. The focus on prevention of medical
errors and improved quality of medical care continues to
increase [2,3]. This focus is evident in Norway by the publi-
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reproduction in any medium, provided the orhealth and social services [4], and the multitude of clinical
guidelines available from governmental and professional
sources.
The referral of a patient from a general practitioner
(GP) to a hospital environment represents a transition of
care, in which the major information exchange is
through the written referral letter [5]. This transition of
care represents an important step in the quality of the
care process, and it has been shown that key clinical in-
formation may not be communicated adequately at the
transition of care interface [6]. There has been consider-
able research into the quality of a referral and its impact
on the process of care. A Norwegian study from 2007
amongst elderly patients demonstrated that both referralral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The consequences might represent a health hazard to
older patients [7]. A Finnish assessment of the quality of
referral letters for patients with asthma concludes that
45% of the referrals were of poor or unacceptable qual-
ity, based upon quality criteria developed by GPs and
hospital respiratory consultants [8]. Others have also
found varying quality and content of referrals [9-15].
Many studies have been designed for improving the re-
ferral process from GPs to the hospital [16,17]. A recent
Cochrane review on interventions to improve outpatient
referrals from primary to secondary care concludes that
surprisingly few interventions on the referral system have
been rigorously evaluated. Many of the studies evaluated
focused only on referral rates or referral quality. The re-
view highlights the complexities of research in this area,
especially as no single study managed to present findings
on all aspects of the referral process (referral behavior,
management of non-referred patients, secondary care
management of patients, the flow of patients through the
referral system, patient outcomes and satisfaction, and
resource use). However, structured referral sheets and
local education interventions have an impact on referral
rates [18].
The primary objective of the present study is to evalu-
ate whether the implementation of a referral template in
the referral from general practice to hospital care can
lead to a measurable increase in the quality of care deliv-
ered at the hospital. As secondary objectives, we will as-
sess patient satisfaction and effective prioritization at
secondary care.Methods
Study design
This study is a cluster randomized trial, with the GP
clinics as the cluster. The local GP clinics are randomly
assigned either to use a referral template or to continue
standard referral practice.Participants
The 14 community GP practices in the area primarily
served by University Hospital of North Norway Harstad
(UNN Harstad) were included in the randomization
process, with a total list size of 35,490 patients. In
Norway, each individual has a regular GP. These GPs act
as gatekeepers to secondary care. The health care system
is relatively uniform throughout the country. In the study
area, access to specialist care is practically impossible
without a GP referral, whereas some access is possible in
other areas of the country.
The study population will consist of patients referred
to the medical department at UNN Harstad. The refer-
rals received are, almost exclusively, electronic. Children(<18 years of age) and patients with reduced capacity to
consent will be excluded from participation in the study.
Randomization
The GP clinics were randomized stratified by location, to
ensure adequate selection of cases and equal sociodemo-
graphic background data. Five of the centers are larger
town-based centers and nine are smaller, more rural
centers. The location of the center was not expected to in-
fluence the outcome variables. Initially, two centers
approached declined the invitation to participate in the
study, and therefore two additional GP clinics were ran-
domly selected, as illustrated by Figure 1.
Recruitment
New patients referred to the medical department within
one of the four diagnostic groups described below will
receive written information and a consent form together
with their appointment letter. These will be sent out by
a clinic nurse unaware of the status of the GP center
sending the referral (intervention or control). Patients
will be orally reminded at the appointment and may be
given a new consent form. This process is illustrated in
Figure 2.
Intervention
The referral templates have been developed based upon
international literature [19-27] and in collaboration with
local specialists in the appropriate medical field. The tem-
plates have also been through a process of clinical assess-
ment from subspecialists in other northern Norwegian
hospitals. In acknowledging the problems in earlier studies
with the uptake of referral interventions [17,18] we have
deliberately reduced the number of items in the referral
templates, to ensure ease of uptake. Only information that
the medical consultants thought imperative in the referral
have been included as items in the templates. The study
will implement referral guidelines for the following four
diagnostic groups:
 patients referred with dyspepsia;
 patients referred with suspected colonic malignancy;
 patients referred with chest pain;
 patients referred with chronic obstructive
pulmonary disease or suspected chronic obstructive
pulmonary disease.
These diagnostic groups were chosen as they represent
a substantial number of the referrals to a medical de-
partment (own data, 2008). They also represent a clear
diagnostic challenge in primary care and are adept for
simple referral guidelines.
The GPs at the intervention offices will use the referral
template when initiating a new referral process for a
Figure 1 Flow chart of randomization process. ‡ From the four rural clinics initially randomized to the intervention group, two clinics refused.
Therefore two additional rural clinics, from the five rural clinics initially randomized to the control group were randomized, and consented to,
the intervention.
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templates have been distributed as electronic templates
as well as hard copies. The templates function as guide-
lines, but are not implemented as compulsory electronic
checklists. The intervention referrals are sent to a separ-
ate electronic inbox at the hospital. The further evalu-
ation and process of care has not been altered in the
intervention group compared with the standard referral
practice in the control group (Figure 3).
In addition, questionnaires have been developed that
assess patient experiences within the care framework,
with one questionnaire designed for inpatients and one
for outpatients. These questionnaires have been pro-
duced by combining questions from previously validated
questionnaires regarding patient experiences in general
and with transitional care. They include questions fromFigure 2 Recruitment process. Recruitment of patients in both the interva Norwegian patient experiences questionnaire [28]);
two questions about health interaction from the Com-
monwealth Fund Survey 2010 [29]; the Care Transitions
Measure 3 [30]; and demographic questions.
The questionnaires have been reviewed through an
interview process with patients. This was done to ensure
that the forms are acceptable to patients and to highlight
possible issues that patients felt were missing from the
questionnaires.
Objectives
We aim to examine the impact of a referral template on
the process of care, at the individual level. The primary
hypothesis is that the use of a referral template in the
communication between the GP and secondary care will
lead to a measurable increase in the quality of healthention and control groups follow the same procedure.
Figure 3 Referral pathway. Flow of referral and process of care in the intervention (blue arrows) and control group (red arrows).
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use of a referral template in the communication between
a GP and secondary care will lead to:
 a measurable improvement in referral quality;
 a change (up or down) in the number of patients
defined as being in need of prioritization (as defined
in national guidelines for prioritization in health
care [20,23,24]);
 more appropriate prioritization, as measured by final
diagnosis;
 an increase in the ‘appropriateness’ of the referrals
(positive predictive value (PPV) of referral [31];
 and better patient satisfaction, as measured by self-
report questionnaires.
Outcomes
The primary outcome will be a quality indicator score
compared between the intervention and the control group.
The quality indicators have been generated from previous
international quality assessment tools and national and
international treatment guidelines. Some adaptation tolocally accepted practice has been made, as demonstrated
by others when quality indicators are used in a new context
[32]. Each patient care process will be scored according to
the criteria. Scoring will be done by a panel of specialists
blinded to the intervention status of the patient. We will
calculate the quality score as adherence scores (number of
quality criteria met divided by number of applicable criteria
expressed as a percentage) as illustrated by Ashton et al.
[33]. If a criterion is applicable, but no information can be
found (applicable, but not answerable), it will be noted ‘not
met’ for statistical purposes [34]. Weighting of the criteria
based upon clinical importance will not be used, as this
adds complexity without adding much to the clinical find-
ings, a finding discussed by Lyons and Payne in 1975 [35].
The scores will be compared between the intervention and
control groups.
As secondary outcomes, the quality of the referrals will
be evaluated against the developed referral template, to de-
termine if the intervention has led to improved referral
quality. It is important to measure referral quality, as the
premise in the study is that more information will lead to
improved care. In addition, health process outcomes such
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appointments before a diagnosis is reached, time before
treatment is initiated, the application or not of appoint-
ment prioritization, and the outcome of any given referral
(appointment, return information or referral rejected) will
be collected and compared between the groups. Bennett
et al. used the PPV of a referral as a measure of the appro-
priateness of the referral [31]. In adapting this concept
from glue ear in otolaryngology to a medical department
we have defined it as the proportion of the GP referrals
that result in a histological diagnosis, diagnostic clarifica-
tion or change in medical management. We will assess and
compare the PPV of referrals in the study groups. Patient
experiences will be compared between the intervention
and control group. Finally, the possible outcome diagnoses
have been grouped according to severity. We will correlate
the continuous outcome variable ‘waiting time’ with the
grouped severity, to see whether the prioritization in the
intervention group is more aligned with disease severity.
Sample size
Sample size was calculated based upon the primary out-
come, and the initial calculation was done without re-
gard for clustering. A change in the quality score of 10%
was determined to be clinically interesting. Setting the
significance level at 0.05 and using PASS 2008 (NCSS,
LLC, Kaysville, UT, USA) for the calculation provides
that the study would require 855 patients in the control
and 855 in the intervention group, for an 80% power to
detect a 10% difference between the groups.
To correct for clustering, the design effect (DE) may
be calculate as:
DE = 1 + ρ(m-1)
where ρ denoted the intracluster correlation coefficient
(ICC) and m is the size of each cluster [36]. No ICC for
equivalent designs was identified from literature searches.
Reviewing primary care-based interventions from the
literature [37-39], an expected ICC ranging from 0.001 to
0.08 does not seem improbable, giving a DE of 1.15 and
12.9, respectively, for a cluster size of 150 patients. Be-
cause only 14 GP clinics were available for randomization,
further inflation of the number of clusters to achieve
higher power was not possible, although this could have
been advisable [40].
Based upon a review of patient data at UNN Harstad
from 2008, the study is expected to achieve this rela-
tively high inclusion number by recruiting over a two-
year period (personal data).
Blinding
The referring GP cannot be blinded to the trial, as the
intervention is actively used by the GP. The patient willnot be aware of the intervention, but no active effort has
been made to keep the patients blinded. The patients
will be mixed with the general caseload to avoid bias in
the treatment process at the hospital. For the GPs that
use the electronic referral template, this usage will be
visible to the hospital doctor in the presentation of the
referral letter on the computer, but for the majority of
the cases the hospital doctor will be blinded to the inter-
vention status of the patient. The outcome assessors will
be blinded.
Data gathering
Data will be extracted by both automated computer
reports (for example, waiting times, number of appoint-
ments) and manual chart review (for example, PPV,
group of final diagnosis). Data will be collected after the
process of care that the referral initiated is completed.
Statistical methods
We will collect the following baseline characteristics:
 patient age (mean and confidence interval) and sex
(number and percentage)
 practice list size (median and interquartile range, or
mean and confidence interval if normally
distributed)
 referral type - electronic or paper (number and
percentage)
 referred by - GP or other doctor (number and
percentage).
For the primary outcome (quality score), we will calcu-
late adherence scores as described above and compare
between treatment arms. We expect substantial variation
in cluster size. Because of the small number of clusters,
analysis based upon the cluster level was considered
[41]. However, as there is no prior accurate estimate of
variation between clusters, weighting for cluster size
could not be achieved [41]. To offer increased precision
and take into account between-cluster variation, random
effects linear regression will be used [42] to generate esti-
mates of intervention effect. It has been suggested that this
can be used for studies with as few as 10 clusters [36]. The
estimated effect and confidence intervals will be reported.
A P-value <0.05 will be regarded as statistically significant.
Intention to treat analysis will be employed.
The referrals will be scored using a simple scoring sys-
tem related to the referral templates. Each unit of infor-
mation specified in the referral template (for example,
presence of weight loss specified) will provide one point
in the scoring system, with no weighting applied. Scores
will be compared between the groups as noted above.
For outcome severity, random effects linear regression
will be used, with the severity group score as a categorical
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vention and control group.
In the questionnaire, answers noted as ‘not applicable’
or no answer will be counted as missing data. The ques-
tionnaire will be scored according to a pre-set scoring
system. Scores will be analyzed using the regression
technique outlined above. The data will also be analyzed
to determine if factors such as self-perceived health, age,
gender, and education level have an impact on patient
experience.
The trial will be reported according to the CONSORT
standards for reporting cluster randomized trials [43].
Pilot study
No pilot study has been carried out. To ensure accept-
ability of the intervention, GPs were invited to, and par-
ticipated in, the development of the referral template.
To ensure feasibility, the authors have collected all data
specified in the protocol from the 20 patients included
first. To ensure an adequate uptake of the intervention,
regular reviews of all referrals received at UNN Harstad
will be undertaken.
Ethics
The study will follow the directions in the Helsinki
Declaration, and was presented to the Regional Ethical
Committee for Medical Research in northern Norway,
who determined it not to be within the scope of the
Health Research Act (REK NORD 2010/2259). The pro-
ject has been approved by the Data Protection Official for
Research. The study is registered at ClinicalTrials.gov. The
trial registration number is NCT01470963. All patients
must provide written informed consent.
Discussion
Transitions of care represent a point of frequent adverse
events [44,45]. The referral is the main form of commu-
nication in the transition from primary to secondary
care [13,46]. Although many referral interventions have
been evaluated, there appears to be limited knowledge
on how the referral letters affect specialist care. A recent
study protocol describes a similar project within mental
health care [47], although this study is still ongoing. The
primary objective of our study is to assess whether an
improved referral letter will lead to a measurable change
in the quality of care delivered in a medical department.
The aim is to go beyond an assessment of referral qual-
ity and waiting times per se, and evaluate quality of care
and the appropriateness of waiting times and treatment,
and, as such, help fill parts of the knowledge gap identi-
fied in a Cochrane review on the subject [18].
However, research at the interface between primary
and secondary care can be challenging [18,48]. The
choice of using an intervention with intuitive contentwas made to make it acceptable in normal general prac-
tice. The assumption underlying this research project is
that a referral guideline will increase the amount of infor-
mation available to the hospital specialist, and that this
increase in information will translate into better care.
The cluster design was chosen because randomization
with this approach is well suited for interventions imple-
mented at the level of the health care organizational unit
[42]. In addition, randomizing at the individual patient
level would undermine findings, as the GPs could use
the information learned from the referral template in
their non-intervention referrals and as such contaminate
the data. For similar reasons, the GP clinic, as opposed
to the individual GP, was randomized, as contamination
between GPs in the same clinic was to be expected.
In choosing a cluster randomized design, we have a
design that is less statistically efficient than a standard
randomized design. A recent study involving a more
complex intervention [49] used randomization at the pa-
tient level to avoid this problem. We feel that the dan-
gers of contamination with individual randomization in
our design would be so large that results would be diffi-
cult to interpret.
In cluster randomized trials, post randomization bias
has been identified as a concern [40]. This entails the re-
cruitment of different cohorts in the intervention and
control groups, as the patients are recruited after
randomization of the clusters. We hope to reduce this
by actively recruiting the patients (obtaining signed con-
sent) in conjunction with the hospital appointment, both
for the intervention and control groups.
The intervention is intentionally simple to ensure that
an effect seen can be attributed to the intervention.
However, an intervention at an interface in a compli-
cated health care system can quickly affect the entire
process, in ways we have not yet envisaged.
There is also a risk of performance bias as systematic
differences in the care may not be due to the interven-
tion, but rather because the doctors will be aware of the
study protocol. By ensuring the mixing of cases in nor-
mal workloads and, as much as possible, blinding the
doctors involved, we hope to minimize this bias. The
fact that the care process is being studied may change
the behavior of the doctors in general, akin to a Haw-
thorn effect. This will potentially attenuate the effects of
the intervention, as the quality of care may improve for
both intervention and control patients.
The authors also recognize that many referrals from
primary to secondary care are not made only to identify
major pathology. Referrals are also made to reassure the
patient, reduce medico-legal risk, obtain a second opin-
ion or for handing over of care [50]. The authors fully
appreciate these as valid reasons for referral. We, there-
fore, do not aim to reduce the number of referrals, but
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referrals.
This study aims to add to the knowledge regarding the
effect of the referral on the patient pathway and quality
of care. Simple diagnostic groups have been chosen. If
the study can identify benefits from improving referrals
in these areas, this may lead the way to further imple-
mentations of referral proforma, preferably electronically
integrated into the standard software packages. This
could improve the overall referral process to enable bet-
ter care and effective prioritization based upon the need
of the individual patients.
Trial status
The study began including patients in the fall of 2011
and inclusion is planned for approximately two years.
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